Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 4th edition, 372 pages

+ the daily Top 10


  Breast Cancer

  Free Subscription


Articles published in Eur J Surg Oncol

Retrieve available abstracts of 132 articles:
HTML format



Single Articles


    June 2020
  1. GHIDINELLI F, Bianchi A
    COVID-19 and breast cancer: Impact on patients and breast care centers.
    Eur J Surg Oncol. 2020 Jun 17. pii: S0748-7983(20)30550.
    PubMed    


  2. MARTA GN
    Radiation therapy after nipple-sparing and skin-sparing mastectomies for early-stage breast cancer patients: Too many uncertainties in clinical practice.
    Eur J Surg Oncol. 2020 Jun 14. pii: S0748-7983(20)30527.
    PubMed    


    April 2020
  3. TASOULIS MK, Roche N, MacNeill F
    Rationalizing breast cancer surgery during the COVID-19 pandemic.
    Eur J Surg Oncol. 2020 Apr 29. pii: S0748-7983(20)30446.
    PubMed    


  4. SCHLAGNITWEIT P, Helfgott R, Theodosiadi S, Mascherbauer M, et al
    Impact of contemporary therapy- concepts on surgical morbidity in breast cancer patients: A retrospective single center analysis of 829 patients.
    Eur J Surg Oncol. 2020 Apr 27. pii: S0748-7983(20)30431.
    PubMed     Abstract available


  5. VICINI E, Galimberti V, Naninato P, Anna Rita AR, et al
    COVID-19: The European institute of oncology as a "hub" centre for breast cancer surgery during the pandemic in Milan (Lombardy region, northern Italy) - A screenshot of the first month.
    Eur J Surg Oncol. 2020 Apr 24. pii: S0748-7983(20)30423.
    PubMed    


    March 2020
  6. CHUN YS, Mizuno T, Cloyd JM, Ha MJ, et al
    Hepatic resection for breast cancer liver metastases: Impact of intrinsic subtypes.
    Eur J Surg Oncol. 2020 Mar 28. pii: S0748-7983(20)30373.
    PubMed     Abstract available


  7. MEANI F, Kovacs T, Spanic T, Costa A, et al
    Breast cancer treatment in the modern era of multidisciplinary oncology: Now we need new models of training.
    Eur J Surg Oncol. 2020 Mar 26. pii: S0748-7983(20)30368.
    PubMed    


  8. HEIL J, Pfob A, Kuerer HM
    De-escalation towards omission is the tipping point of individualizing breast cancer surgery.
    Eur J Surg Oncol. 2020 Mar 19. pii: S0748-7983(20)30355.
    PubMed     Abstract available


    February 2020
  9. MISERE R, Schop S, Heuts E, de Grzymala AP, et al
    Psychosocial well-being at time of diagnosis of breast cancer affects the decision whether or not to undergo breast reconstruction.
    Eur J Surg Oncol. 2020 Feb 25. pii: S0748-7983(20)30127.
    PubMed     Abstract available


  10. KHALAYLEH H, Khalayleh M, Diment J, Allweis TM, et al
    Breast density does not affect breast cancer tumor size assessment: A comparison of radiologic versus pathologic measurement by different imaging modalities across breast densities.
    Eur J Surg Oncol. 2020 Feb 22. pii: S0748-7983(20)30132.
    PubMed     Abstract available


  11. LAI HW, Mok CW, Chang YT, Chen DR, et al
    Endoscopic assisted breast conserving surgery for breast cancer: Clinical outcome, learning curve, and patient reported aesthetic results from preliminary 100 procedures.
    Eur J Surg Oncol. 2020 Feb 20. pii: S0748-7983(20)30122.
    PubMed     Abstract available


  12. SUNDEN M, Hermansson C, Taflin H, Andersson A, et al
    Surgical treatment of breast cancer liver metastases - A nationwide registry-based case control study.
    Eur J Surg Oncol. 2020 Feb 15. pii: S0748-7983(20)30110.
    PubMed     Abstract available


    January 2020
  13. POPOWICH B, Kostaras X, Temple-Oberle C
    Breast reconstruction after therapeutic or prophylactic mastectomy for breast cancer: A comparison of guideline recommendations.
    Eur J Surg Oncol. 2020 Jan 18. pii: S0748-7983(20)30043.
    PubMed     Abstract available


  14. DE LORENZI F, Corso G, Botta F, Invento A, et al
    Immediate breast reconstruction with latissimus dorsi flap for patients with local recurrence of breast cancer.
    Eur J Surg Oncol. 2020 Jan 11. pii: S0748-7983(20)30019.
    PubMed     Abstract available


  15. REDDINGTON R, Galer M, Hagedorn A, Liu P, et al
    Incidence of male breast cancer in Scotland over a twenty-five-year period (1992-2017).
    Eur J Surg Oncol. 2020 Jan 8. pii: S0748-7983(20)30013.
    PubMed     Abstract available


  16. FANCELLU A, Sanna V
    High mastectomy rates in young and very young patients with breast cancer. Are they justified?
    Eur J Surg Oncol. 2020 Jan 1. pii: S0748-7983(19)31520.
    PubMed    


    December 2019
  17. AMELOT A, Terrier LM, Cristini J, Buffenoir K, et al
    Survival in breast cancer patients with spine metastases: Prognostic assessment involving molecular markers.
    Eur J Surg Oncol. 2019 Dec 25. pii: S0748-7983(19)31522.
    PubMed     Abstract available


  18. BALASUBRAMIAN R, Morgan C, Shaari E, Kovacs T, et al
    Wire guided localisation for targeted axillary node dissection is accurate in axillary staging in node positive breast cancer following neoadjuvant chemotherapy.
    Eur J Surg Oncol. 2019 Dec 11. pii: S0748-7983(19)31500.
    PubMed     Abstract available


  19. ASAOKA M, Narui K, Suganuma N, Chishima T, et al
    Clinical and pathological predictors of recurrence in breast cancer patients achieving pathological complete response to neoadjuvant chemotherapy.
    Eur J Surg Oncol. 2019;45:2289-2294.
    PubMed     Abstract available


    November 2019
  20. RUBIO IT, Kontos M, Vrancken-Peeters M, Rouzier R, et al
    Missed opportunities and challenges for surgical breast cancer research in the era of personalized cancer treatment.
    Eur J Surg Oncol. 2019 Nov 20. pii: S0748-7983(19)31447.
    PubMed    


  21. ALLWEIS TM, Menes T, Rotbart N, Rapson Y, et al
    Ultrasound guided tattooing of axillary lymph nodes in breast cancer patients prior to neoadjuvant therapy, and identification of tattooed nodes at the time of surgery.
    Eur J Surg Oncol. 2019 Nov 16. pii: S0748-7983(19)31445.
    PubMed     Abstract available


  22. MORGAN C, Stringfellow TD, Rolph R, Kovacs T, et al
    Neoadjuvant chemotherapy in patients with breast cancer: Does response in the breast predict axillary node response?
    Eur J Surg Oncol. 2019 Nov 12. pii: S0748-7983(19)31442.
    PubMed     Abstract available


  23. JIMBO K, Kinoshita T, Ogura T, Watase C, et al
    Prediction score model for non-sentinel and four or more nodal metastases using a combined method of one-step nucleic acid amplification and histology in sentinel node-positive breast cancer patients.
    Eur J Surg Oncol. 2019 Nov 1. pii: S0748-7983(19)30920.
    PubMed     Abstract available


    October 2019
  24. FRANCESCHINI G
    Sentinel node biopsy after neoadjuvant chemotherapy for breast cancer in patients with pre-treatment node-positive: Recommendations to optimize the performance.
    Eur J Surg Oncol. 2019 Oct 24. pii: S0748-7983(19)30900.
    PubMed    


  25. SIMONS JM, Maaskant-Braat AJG, Luiten EJT, Leidenius MH, et al
    Reply to: Sentinel node biopsy after neoadjuvant chemotherapy for breast cancer in patients with pre-treatment node-positive: Recommnendation to optimize the performance.
    Eur J Surg Oncol. 2019 Oct 22. pii: S0748-7983(19)30902.
    PubMed    


  26. MARKOPOULOS C, Hyams DM, Gomez HL, Harries M, et al
    Multigene assays in early breast cancer: Insights from recent phase 3 studies.
    Eur J Surg Oncol. 2019 Oct 15. pii: S0748-7983(19)30899.
    PubMed     Abstract available


  27. LUCIDI V, Bohlok A, Liberale G, Bez M, et al
    Extended time interval between diagnosis and surgery does not improve the outcome in patients operated for resection or ablation of breast cancer liver metastases.
    Eur J Surg Oncol. 2019 Oct 12. pii: S0748-7983(19)30896.
    PubMed     Abstract available


  28. GOLSHAN M, Wong SM, Loibl S, Huober JB, et al
    Early assessment with magnetic resonance imaging for prediction of pathologic response to neoadjuvant chemotherapy in triple-negative breast cancer: Results from the phase III BrighTNess trial.
    Eur J Surg Oncol. 2019 Oct 5. pii: S0748-7983(19)30883.
    PubMed     Abstract available


    September 2019
  29. PERHAVEC A, Miklavcic M, Peric B, Pilko G, et al
    Is preoperative ultrasound of the axilla necessary in screen-detected breast cancer?
    Eur J Surg Oncol. 2019 Sep 19. pii: S0748-7983(19)30813.
    PubMed     Abstract available


  30. KIM R, Kawai A, Wakisaka M, Sawada S, et al
    Immune correlates of the differing pathological and therapeutic effects of neoadjuvant chemotherapy in breast cancer.
    Eur J Surg Oncol. 2019 Sep 18. pii: S0748-7983(19)30812.
    PubMed     Abstract available


    August 2019
  31. SIMONS JM, Maaskant-Braat AJG, Luiten EJT, Leidenius MHK, et al
    Patterns of axillary staging and management in clinically node positive breast cancer patients treated with neoadjuvant systemic therapy: Results of a survey amongst breast cancer specialists.
    Eur J Surg Oncol. 2019 Aug 13. pii: S0748-7983(19)30627.
    PubMed     Abstract available


  32. GARCIA-ETIENNE CA, Ferrari A, Della Valle A, Lucioni M, et al
    Management of the axilla in patients with breast cancer and positive sentinel lymph node biopsy: An evidence-based update in a European breast center.
    Eur J Surg Oncol. 2019 Aug 13. pii: S0748-7983(19)30628.
    PubMed     Abstract available


  33. JAUHARI Y, Gannon MR, Dodwell D, Horgan K, et al
    Addressing frailty in patients with breast cancer: A review of the literature.
    Eur J Surg Oncol. 2019 Aug 12. pii: S0748-7983(19)30623.
    PubMed     Abstract available


  34. ALTUNDAG K
    Complete response to systemic treatment might predict better survival rates regardless of their metastatic patterns in de novo stage IV breast cancer patients undergoing primary surgery.
    Eur J Surg Oncol. 2019 Aug 8. pii: S0748-7983(19)30618.
    PubMed    


  35. BEEK MA, Gobardhan PD, Klompenhouwer EG, Menke-Pluijmers MB, et al
    A patient- and assessor-blinded randomized controlled trial of axillary reverse mapping (ARM) in patients with early breast cancer.
    Eur J Surg Oncol. 2019 Aug 5. pii: S0748-7983(19)30615.
    PubMed     Abstract available


    July 2019
  36. CORSO G, Sacchini V, Pravettoni G, Veronesi P, et al
    Familial lobular breast cancer: Is testing for germline CDH1 mutations necessary?
    Eur J Surg Oncol. 2019 Jul 19. pii: S0748-7983(19)30578.
    PubMed    


  37. DI MICCO R, Zuber V, Fiacco E, Carriero F, et al
    Corrigendum to "Sentinel node biopsy after primary systemic therapy in node positive breast cancer patients: Time trend, imaging staging power and nodal downstaging according to molecular subtype" [Eur. J. Surg. Oncol. 45, (6) (2019) 969-975].
    Eur J Surg Oncol. 2019 Jul 13. pii: S0748-7983(19)30544.
    PubMed    


    June 2019
  38. ZACHARIOUDAKIS K, Down S, Bholah Z, Lee S, et al
    Is the future magnetic? Magseed localisation for non palpable breast cancer. A multi-centre non randomised control study.
    Eur J Surg Oncol. 2019 Jun 26. pii: S0748-7983(19)30529.
    PubMed     Abstract available


  39. ABBACI M, Conversano A, De Leeuw F, Laplace-Builhe C, et al
    Near-infrared fluorescence imaging for the prevention and management of breast cancer-related lymphedema: A systematic review.
    Eur J Surg Oncol. 2019 Jun 8. pii: S0748-7983(19)30503.
    PubMed     Abstract available


  40. SZOLLAR A, Ujhelyi M, Polgar C, Olah E, et al
    A long-term retrospective comparative study of the oncological outcomes of 598 very young (</=35 years) and young (36-45 years) breast cancer patients.
    Eur J Surg Oncol. 2019 Jun 5. pii: S0748-7983(19)30498.
    PubMed     Abstract available


    May 2019
  41. SORRENTINO L, Regolo L, Scoccia E, Petrolo G, et al
    Autologous fat transfer after breast cancer surgery: An exact-matching study on the long-term oncological safety.
    Eur J Surg Oncol. 2019 May 21. pii: S0748-7983(19)30451.
    PubMed     Abstract available


  42. SAVOLT A, Cserni G, Lazar G, Maraz R, et al
    Sentinel lymph node biopsy following previous axillary surgery in recurrent breast cancer.
    Eur J Surg Oncol. 2019 May 16. pii: S0748-7983(19)30454.
    PubMed     Abstract available


  43. DRAKE TM, Soreide K
    Cancer epigenetics in solid organ tumours: A primer for surgical oncologists.
    Eur J Surg Oncol. 2019;45:736-746.
    PubMed     Abstract available


    April 2019
  44. RAMSINGH J, O'Dwyer P, Watson C
    Survival outcomes following adrenalectomy for isolated metastases to the adrenal gland.
    Eur J Surg Oncol. 2019;45:631-634.
    PubMed     Abstract available


  45. FORESTER ND, Lowes S, Mitchell E, Twiddy M, et al
    High risk (B3) breast lesions: What is the incidence of malignancy for individual lesion subtypes? A systematic review and meta-analysis.
    Eur J Surg Oncol. 2019;45:519-527.
    PubMed     Abstract available


  46. VAN BOCKSTAL M, Lambein K, Smeets A, Slembrouck L, et al
    Stromal characteristics are adequate prognosticators for recurrence risk in ductal carcinoma in situ of the breast.
    Eur J Surg Oncol. 2019;45:550-559.
    PubMed     Abstract available


    March 2019
  47. SAVAGE P, Yu N, Dumitra S, Meterissian S, et al
    The effect of the American Joint Committee on Cancer eighth edition on breast cancer staging and prognostication.
    Eur J Surg Oncol. 2019 Mar 23. pii: S0748-7983(19)30355.
    PubMed     Abstract available


  48. VAN BOCKSTAL MR, Monstrey SJ, van Deurzen CHM
    The role of routine histopathology after chest-contouring surgery in transmen.
    Eur J Surg Oncol. 2019;45:485-486.
    PubMed    


    February 2019
  49. WANG K, Shi Y, Li ZY, Xiao YL, et al
    Metastatic pattern discriminates survival benefit of primary surgery for de novo stage IV breast cancer: A real-world observational study.
    Eur J Surg Oncol. 2019 Feb 19. pii: S0748-7983(19)30283.
    PubMed     Abstract available


  50. NIINIKOSKI L, Leidenius MHK, Vaara P, Voynov A, et al
    Resection margins and local recurrences in breast cancer: Comparison between conventional and oncoplastic breast conserving surgery.
    Eur J Surg Oncol. 2019 Feb 11. pii: S0748-7983(19)30279.
    PubMed     Abstract available


  51. WALSTRA CJEF, Schipper RJ, Poodt IGM, van Riet YE, et al
    Repeat breast-conserving therapy for ipsilateral breast cancer recurrence: A systematic review.
    Eur J Surg Oncol. 2019 Feb 10. pii: S0748-7983(19)30277.
    PubMed     Abstract available


  52. RUSSO L, Maltese A, Betancourt L, Romero G, et al
    Locally advanced breast cancer: Tumor-infiltrating lymphocytes as a predictive factor of response to neoadjuvant chemotherapy.
    Eur J Surg Oncol. 2019 Feb 4. pii: S0748-7983(19)30248.
    PubMed     Abstract available


  53. SORAN A
    Are we close to the end of the primary tumor resection discussion for de novo stage IV BC?
    Eur J Surg Oncol. 2019;45:81-82.
    PubMed    


  54. ESGUEVA A, Rodriguez-Revuelto R, Espinosa-Bravo M, Salazar JP, et al
    Learning curves in intraoperative ultrasound guided surgery in breast cancer based on complete breast cancer excision and no need for second surgeries.
    Eur J Surg Oncol. 2019 Feb 1. pii: S0748-7983(19)30040.
    PubMed     Abstract available


  55. COSTARELLI L, Cianchetti E, Corsi F, Friedman D, et al
    Microinvasive breast carcinoma: An analysis from ten Senonetwork Italia breast centres.
    Eur J Surg Oncol. 2019;45:147-152.
    PubMed     Abstract available


  56. SUTINEN M, Kontunen A, Karjalainen M, Kiiski J, et al
    Identification of breast tumors from diathermy smoke by differential ion mobility spectrometry.
    Eur J Surg Oncol. 2019;45:141-146.
    PubMed     Abstract available


  57. KELEMEN P, Pukancsik D, Ujhelyi M, Savolt A, et al
    Comparison of clinicopathologic, cosmetic and quality of life outcomes in 700 oncoplastic and conventional breast-conserving surgery cases: A single-centre retrospective study.
    Eur J Surg Oncol. 2019;45:118-124.
    PubMed     Abstract available


  58. KIM I, Choi HJ, Ryu JM, Lee SK, et al
    A predictive model for high/low risk group according to oncotype DX recurrence score using machine learning.
    Eur J Surg Oncol. 2019;45:134-140.
    PubMed     Abstract available


    January 2019
  59. MICCO RD, Zuber V, Fiacco E, Carriero F, et al
    Sentinel node biopsy after primary systemic therapy in node positive breast cancer patients: Time trend, imaging staging power and nodal downstaging according to molecular subtype.
    Eur J Surg Oncol. 2019 Jan 31. pii: S0748-7983(19)30245.
    PubMed     Abstract available


  60. OJALA K, Meretoja TJ, Mattson J, Leidenius MHK, et al
    Surgical treatment and prognosis of breast cancer in elderly - A population-based study.
    Eur J Surg Oncol. 2019 Jan 21. pii: S0748-7983(19)30042.
    PubMed     Abstract available


  61. METS EJ, Chouairi FK, Gabrick KS, Avraham T, et al
    Persistent disparities in breast cancer surgical outcomes among hispanic and African American patients.
    Eur J Surg Oncol. 2019 Jan 17. pii: S0748-7983(19)30039.
    PubMed     Abstract available


  62. VANE MLG, van Nijnatten TJA, Nelemans PJ, Lobbes MBI, et al
    Does the subtype of breast cancer affect the diagnostic performance of axillary ultrasound for nodal staging in breast cancer patients?
    Eur J Surg Oncol. 2019 Jan 14. pii: S0748-7983(19)30035.
    PubMed     Abstract available


  63. RUBIO IT, Wyld L, Esgueva A, Kovacs T, et al
    Variability in breast cancer surgery training across Europe: An ESSO-EUSOMA international survey.
    Eur J Surg Oncol. 2019 Jan 5. pii: S0748-7983(19)30003.
    PubMed     Abstract available


  64. BRAHMA B, Yamamoto T
    Breast cancer treatment-related lymphedema (BCRL): An overview of the literature and updates in microsurgery reconstructions.
    Eur J Surg Oncol. 2019 Jan 4. pii: S0748-7983(19)30004.
    PubMed     Abstract available


  65. VAN EGDOM LSE, Lagendijk M, van der Kemp MH, van Dam JH, et al
    Implementation of Value Based Breast Cancer Care.
    Eur J Surg Oncol. 2019 Jan 4. pii: S0748-7983(19)30007.
    PubMed     Abstract available


    December 2018
  66. HEEG E, Schreuder K, Spronk PER, Oosterwijk JC, et al
    Hospital transfer after a breast cancer diagnosis: A population-based study in the Netherlands of the extent, predictive characteristics and its impact on time to treatment.
    Eur J Surg Oncol. 2018 Dec 29. pii: S0748-7983(18)32039.
    PubMed     Abstract available


  67. QIAO W, Liu H, Guo W, Li P, et al
    Prognostic and clinical significance of syndecan-1 expression in breast cancer: A systematic review and meta-analysis.
    Eur J Surg Oncol. 2018 Dec 25. pii: S0748-7983(18)32041.
    PubMed     Abstract available


    November 2018
  68. ADAM MJ, Bendifallah S, Kalhorpour N, Cohen-Steiner C, et al
    Time to revise classification of phyllodes tumors of breast? Results of a French multicentric study.
    Eur J Surg Oncol. 2018;44:1743-1749.
    PubMed     Abstract available


  69. AHMEIDAT H, Purdie C, Jordan L, Fleming D, et al
    Non-histopathological parameters associated with upgrade of breast tumours yielding a core biopsy report of histological grade 2 ductal no special type to grade 3 on excision.
    Eur J Surg Oncol. 2018;44:1720-1724.
    PubMed     Abstract available


  70. LIM GH, Lee J, Yen CC
    Virtual breast oncoplastic surgery simulator (VBOSS): A novel training tool in breast surgery.
    Eur J Surg Oncol. 2018;44:1750-1753.
    PubMed     Abstract available


  71. FLANAGAN M, Solon J, Chang KH, Deady S, et al
    Peritoneal metastases from extra-abdominal cancer - A population-based study.
    Eur J Surg Oncol. 2018;44:1811-1817.
    PubMed     Abstract available


  72. YU TJ, Liu YY, Hu X, Di GH, et al
    Survival following breast-conserving therapy is equal to that following mastectomy in young women with early-stage invasive lobular carcinoma.
    Eur J Surg Oncol. 2018;44:1703-1707.
    PubMed     Abstract available


    October 2018
  73. HERSI AF, Eriksson S, Ramos J, Abdsaleh S, et al
    A combined, totally magnetic technique with a magnetic marker for non-palpable tumour localization and superparamagnetic iron oxide nanoparticles for sentinel lymph node detection in breast cancer surgery.
    Eur J Surg Oncol. 2018 Oct 23. pii: S0748-7983(18)31467.
    PubMed     Abstract available


  74. LAI HW, Wang CC, Lai YC, Chen CJ, et al
    The learning curve of robotic nipple sparing mastectomy for breast cancer: An analysis of consecutive 39 procedures with cumulative sum plot.
    Eur J Surg Oncol. 2018 Oct 17. pii: S0748-7983(18)31440.
    PubMed     Abstract available


  75. SPRONK PER, Volders JH, van den Tol P, Smorenburg CH, et al
    Breast conserving therapy after neoadjuvant chemotherapy; data from the Dutch Breast Cancer Audit.
    Eur J Surg Oncol. 2018 Oct 17. pii: S0748-7983(18)31447.
    PubMed     Abstract available


  76. HELFGOTT, Mittlbock, Miesbauer, Moinfar, et al
    The influence of breast cancer subtypes on axillary ultrasound accuracy: A retrospective single center analysis of 583 women.
    Eur J Surg Oncol. 2018 Oct 10. pii: S0748-7983(18)31367.
    PubMed     Abstract available


  77. DOROGI B, Bukovszky B, Matrai T, Savolt A, et al
    Mapping of the functional anatomy of lymphatic drainage to the axilla in early breast cancer: A cohort study of 933 cases.
    Eur J Surg Oncol. 2018 Oct 7. pii: S0748-7983(18)31418.
    PubMed     Abstract available


    September 2018
  78. DE FREITAS TB, Lopes de Barros Lima KM, de Andrade Carvalho H, de Azevedo Marques P, et al
    What a difference a clip makes! Analysis of boost volume definition in radiation therapy for conservative breast surgery.
    Eur J Surg Oncol. 2018;44:1312-1317.
    PubMed     Abstract available


    August 2018
  79. XIAO W, Zou Y, Zheng S, Hu X, et al
    Primary tumor resection in stage IV breast cancer: A systematic review and meta-analysis.
    Eur J Surg Oncol. 2018 Aug 11. pii: S0748-7983(18)31269.
    PubMed     Abstract available


  80. D'ALONZO M, Pecchio S, Campisi P, De Rosa G, et al
    Nipple-Sparing Mastectomy: Reliability of sub-areolar sampling and frozen section in predicting occult nipple involvement in breast cancer patients.
    Eur J Surg Oncol. 2018 Aug 2. pii: S0748-7983(18)31262.
    PubMed     Abstract available


  81. CURIGLIANO G
    Inflammatory breast cancer and chest wall disease: The oncologist perspective.
    Eur J Surg Oncol. 2018;44:1142-1147.
    PubMed     Abstract available


  82. LAI HW, Huang RH, Wu YT, Chen CJ, et al
    Clinicopathologic factors related to surgical margin involvement, reoperation, and residual cancer in primary operable breast cancer - An analysis of 2050 patients.
    Eur J Surg Oncol. 2018 Aug 1. pii: S0748-7983(18)31259.
    PubMed     Abstract available


    July 2018
  83. POODT IGM, Schipper RJ, Vugts G, Woensdregt K, et al
    The rationale for and long-term outcome of incomplete axillary staging in elderly women with primary breast cancer.
    Eur J Surg Oncol. 2018 Jul 27. pii: S0748-7983(18)31184.
    PubMed     Abstract available


  84. HARTLEY RL, Stone JP, Temple-Oberle C
    Breast cancer in transgender patients: A systematic review. Part 1: Male to female.
    Eur J Surg Oncol. 2018 Jul 25. pii: S0748-7983(18)31188.
    PubMed     Abstract available


  85. STONE JP, Hartley RL, Temple-Oberle C
    Breast cancer in transgender patients: A systematic review. Part 2: Female to Male.
    Eur J Surg Oncol. 2018 Jul 5. pii: S0748-7983(18)31165.
    PubMed     Abstract available


  86. QIU SQ, Dorrius MD, de Jongh SJ, Jansen L, et al
    Micro-computed tomography (micro-CT) for intraoperative surgical margin assessment of breast cancer: A feasibility study in breast conserving surgery.
    Eur J Surg Oncol. 2018 Jul 3. pii: S0748-7983(18)31166.
    PubMed     Abstract available


  87. MARTA GN, Poortmans P, de Barros AC, Filassi JR, et al
    Reply to: Mastectomy skin flap thickness.
    Eur J Surg Oncol. 2018;44:1119-1120.
    PubMed    


  88. ROBERTSON SA, Cutress RI
    Mastectomy skin flap thickness.
    Eur J Surg Oncol. 2018;44:1118.
    PubMed    


  89. NAZZANI S, Preisser F, Mazzone E, Tian Z, et al
    In-hospital length of stay after major surgical oncological procedures.
    Eur J Surg Oncol. 2018;44:969-974.
    PubMed     Abstract available


  90. DE LORENZI F, Di Bella J, Maisonneuve P, Rotmensz N, et al
    Oncoplastic breast surgery for the management of ductal carcinoma in situ (DCIS): is it oncologically safe? A retrospective cohort analysis.
    Eur J Surg Oncol. 2018;44:957-962.
    PubMed     Abstract available


  91. TEMPFER CB, Hilal Z, Dogan A, Petersen M, et al
    Concentrations of cisplatin and doxorubicin in ascites and peritoneal tumor nodules before and after pressurized intraperitoneal aerosol chemotherapy (PIPAC) in patients with peritoneal metastasis.
    Eur J Surg Oncol. 2018;44:1112-1117.
    PubMed     Abstract available


  92. ROMICS L, Macaskill EJ, Fernandez T, Simpson L, et al
    A population-based audit of surgical practice and outcomes of oncoplastic breast conservations in Scotland - An analysis of 589 patients.
    Eur J Surg Oncol. 2018;44:939-944.
    PubMed     Abstract available


    June 2018
  93. KAHLERT S, Kolben TM, Schmoeckel E, Czogalla B, et al
    Prognostic impact of residual disease in simultaneous additional excision specimens after one-step breast conserving therapy with negative final margin status in primary breast cancer.
    Eur J Surg Oncol. 2018 Jun 23. pii: S0748-7983(18)31136.
    PubMed     Abstract available


  94. RAFNSDOTTIR SL, Audisio RA
    Inflammatory Breast Cancer: What surgeons need to know.
    Eur J Surg Oncol. 2018 Jun 18. pii: S0748-7983(18)31128.
    PubMed     Abstract available


  95. AUDISIO RA
    Inflammatory Breast Cancer: Updates on diagnosis and treatment options.
    Eur J Surg Oncol. 2018 Jun 18. pii: S0748-7983(18)31123.
    PubMed    


  96. ALTUNDAG K
    Locally advanced non-inflammatory breast cancer may be misdiagnosed as inflammatory breast cancer.
    Eur J Surg Oncol. 2018 Jun 18. pii: S0748-7983(18)31122.
    PubMed    


  97. HARTMANN S, Reimer T, Gerber B, Stubert J, et al
    Wire localization of clip-marked axillary lymph nodes in breast cancer patients treated with primary systemic therapy.
    Eur J Surg Oncol. 2018 Jun 9. pii: S0748-7983(18)31119.
    PubMed     Abstract available


    May 2018
  98. ORECCHIA R
    Radiation therapy for inflammatory breast cancer.
    Eur J Surg Oncol. 2018 May 17. pii: S0748-7983(18)31069.
    PubMed     Abstract available


  99. PAPALOUKA V, Gilbert FJ
    Inflammatory breast cancer-importance of breast imaging.
    Eur J Surg Oncol. 2018 May 16. pii: S0748-7983(18)31058.
    PubMed    


  100. FENTIMAN IS
    Unmet needs of men with breast cancer.
    Eur J Surg Oncol. 2018 May 15. pii: S0748-7983(18)31054.
    PubMed     Abstract available


  101. KARAKATSANIS A, Obondo C, Abdsaleh S, Hersi AF, et al
    Optimisation of breast MRI compatibility after sentinel node biopsy with paramagnetic tracers.
    Eur J Surg Oncol. 2018;44:731-732.
    PubMed    


  102. HASSING CMS, Tvedskov TF, Kroman N, Klausen TL, et al
    Radioactive seed localisation of non-palpable lymph nodes - A feasibility study.
    Eur J Surg Oncol. 2018;44:725-730.
    PubMed     Abstract available


  103. MYLVAGANAM S, Conroy EJ, Williamson PR, Barnes NLP, et al
    Adherence to best practice consensus guidelines for implant-based breast reconstruction: Results from the iBRA national practice questionnaire survey.
    Eur J Surg Oncol. 2018;44:708-716.
    PubMed     Abstract available


    April 2018
  104. CSERNI G, Charafe-Jauffret E, van Diest PJ
    Inflammatory breast cancer: The pathologists' perspective.
    Eur J Surg Oncol. 2018 Apr 18. pii: S0748-7983(18)30998.
    PubMed     Abstract available


  105. WICKBERG A, Liljegren G, Killander F, Lindman H, et al
    Omitting radiotherapy in women >/= 65 years with low-risk early breast cancer after breast-conserving surgery and adjuvant endocrine therapy is safe.
    Eur J Surg Oncol. 2018 Apr 13. pii: S0748-7983(18)31007.
    PubMed     Abstract available


  106. LIM GH, Upadhyaya VS, Acosta HA, Lim JMA, et al
    Preoperative predictors of high and low axillary nodal burden in Z0011 eligible breast cancer patients with a positive lymph node needle biopsy result.
    Eur J Surg Oncol. 2018 Apr 12. pii: S0748-7983(18)31008.
    PubMed     Abstract available


  107. ARISTEI C, Kaidar-Person O, Tagliaferri L, Arenas M, et al
    The Assisi Think Tank Meeting and Survey of post MAstectomy Radiation Therapy after breast reconstruction: The ATTM-SMART report.
    Eur J Surg Oncol. 2018;44:436-443.
    PubMed     Abstract available


  108. MAXWELL AJ, Clements K, Hilton B, Dodwell DJ, et al
    Risk factors for the development of invasive cancer in unresected ductal carcinoma in situ.
    Eur J Surg Oncol. 2018;44:429-435.
    PubMed     Abstract available


  109. KUERER HM
    Navigating treatment controversies for DCIS in the era of genomic profiling and active surveillance trials.
    Eur J Surg Oncol. 2018;44:386-387.
    PubMed    


  110. LAYEEQUR RAHMAN R, Marshall AJ
    Evidence basis for sentinel node biopsy post neoadjuvant chemotherapy - Bias is a 4-letter word.
    Eur J Surg Oncol. 2018;44:541-542.
    PubMed    


    March 2018
  111. VICINI E, Invento A, Cuoghi M, Bafile A, et al
    Neoadjuvant systemic treatment for breast cancer in Italy: The Italian Society of Surgical Oncology (SICO) Breast Oncoteam survey.
    Eur J Surg Oncol. 2018 Mar 31. pii: S0748-7983(18)30987.
    PubMed     Abstract available


  112. LAGENDIJK M, van Egdom LSE, Richel C, van Leeuwen N, et al
    Patient reported outcome measures in breast cancer patients.
    Eur J Surg Oncol. 2018 Mar 21. pii: S0748-7983(18)30954.
    PubMed     Abstract available


    February 2018
  113. ANGARITA FA, Acuna SA, McCready DR, Escallon J, et al
    Management of positive margins after initial lumpectomy in elderly women with breast cancer.
    Eur J Surg Oncol. 2018 Feb 21. pii: S0748-7983(18)30671.
    PubMed     Abstract available


  114. ALTUNDAG K
    Role of endocrine therapy in weak estrogen/progesterone receptor expression in HER2 negative breast cancer.
    Eur J Surg Oncol. 2018 Feb 6. pii: S0748-7983(18)30118.
    PubMed    


  115. DE LIGT KM, van Bommel ACM, Schreuder K, Maduro JH, et al
    The effect of being informed on receiving immediate breast reconstruction in breast cancer patients.
    Eur J Surg Oncol. 2018 Feb 2. pii: S0748-7983(18)30275.
    PubMed     Abstract available


  116. TASOULIS MK, Iqbal FM, Cawthorn S, MacNeill F, et al
    Reply to: Subcutaneous implant breast reconstruction: The importance of objectively assessing the outcomes.
    Eur J Surg Oncol. 2018;44:273.
    PubMed    


  117. ONESTI MG, Fanelli B, Di Taranto G
    Subcutaneous implant breast reconstruction: the importance of objectively assessing the outcomes.
    Eur J Surg Oncol. 2018;44:271-272.
    PubMed    


    January 2018
  118. LIAO GS
    Reply letter to: Role of endocrine therapy in weak estrogen/progesterone receptor expression in HER2 negative breast cancer.
    Eur J Surg Oncol. 2018 Jan 27. pii: S0748-7983(18)30117.
    PubMed    


  119. SASADA S, Masumoto N, Goda N, Kajitani K, et al
    Dedicated breast PET for detecting residual disease after neoadjuvant chemotherapy in operable breast cancer: A prospective cohort study.
    Eur J Surg Oncol. 2018 Jan 17. pii: S0748-7983(18)30044.
    PubMed     Abstract available


  120. QIU SQ, Aarnink M, van Maaren MC, Dorrius MD, et al
    Validation and update of a lymph node metastasis prediction model for breast cancer.
    Eur J Surg Oncol. 2018 Jan 17. pii: S0748-7983(18)30037.
    PubMed     Abstract available


  121. ZHAO S, Ma D, Xiao Y, Jiang YZ, et al
    Clinicopathologic features and prognoses of different histologic types of triple-negative breast cancer: A large population-based analysis.
    Eur J Surg Oncol. 2018 Jan 9. pii: S0748-7983(18)30002.
    PubMed     Abstract available


  122. RUBIO IT
    Variations in the opinion of breast surgeons and radiation oncologist regarding indications for radiation therapy after NSM: The need for prospective studies.
    Eur J Surg Oncol. 2018;44:3-4.
    PubMed    


  123. RECHT A
    Postmastectomy radiation therapy: What factors are important in recommending treatment to patients undergoing "Sparing" mastectomies.
    Eur J Surg Oncol. 2018;44:1-2.
    PubMed    


  124. JANSSEN NNY, van la Parra RFD, Loo CE, Groen EJ, et al
    Breast conserving surgery for extensive DCIS using multiple radioactive seeds.
    Eur J Surg Oncol. 2018;44:67-73.
    PubMed     Abstract available


  125. AHN SK, Han W, Moon HG, Kim MK, et al
    Management of benign papilloma without atypia diagnosed at ultrasound-guided core needle biopsy: Scoring system for predicting malignancy.
    Eur J Surg Oncol. 2018;44:53-58.
    PubMed     Abstract available


  126. NIINIKOSKI L, Hukkinen K, Leidenius MHK, Stahls A, et al
    Breast Lesion Excision System in the diagnosis and treatment of intraductal papillomas - A feasibility study.
    Eur J Surg Oncol. 2018;44:59-66.
    PubMed     Abstract available


    December 2017
  127. ONG JSL, Teh J, Saunders C, Bourke AG, et al
    Patient satisfaction with Radioguided Occult Lesion Localisation using iodine-125 seeds ('ROLLIS') versus conventional hookwire localisation.
    Eur J Surg Oncol. 2017;43:2261-2269.
    PubMed     Abstract available


    November 2017
  128. WESTENEND PJ, Storm R, Kock M, Kitzen J, et al
    The role of ultrasonography of the axilla and fine-needle aspiration cytology in breast cancer patients in the era of neo-adjuvant chemotherapy and axillary radiation; prevention of futile sentinel node procedures revisited.
    Eur J Surg Oncol. 2017 Nov 29. pii: S0748-7983(17)30979.
    PubMed    


  129. KRISCHER B, Forte S, Niemann T, Kubik-Huch RA, et al
    Feasibility of breast MRI after sentinel procedure for breast cancer with superparamagnetic tracers.
    Eur J Surg Oncol. 2017 Nov 26. pii: S0748-7983(17)30978.
    PubMed     Abstract available


  130. BUNDRED NJ
    Erratum to "Impact of Oncotype DX Breast Recurrence Score testing on adjuvant chemotherapy use in early breast cancer: Real world experience in Greater Manchester, UK" [Eur J Surg Oncol 43 (5) (2017) 931-937].
    Eur J Surg Oncol. 2017 Nov 23. pii: S0748-7983(17)30539.
    PubMed    


  131. CHARALAMPOUDIS P, Markopoulos C, Kovacs T
    Controversies and recommendations regarding sentinel lymph node biopsy in primary breast cancer: A comprehensive review of current data.
    Eur J Surg Oncol. 2017 Nov 13. pii: S0748-7983(17)30955.
    PubMed     Abstract available


    August 2017
  132. MARTELLI G, Miceli R, Folli S, Guzzetti E, et al
    Sentinel node biopsy after primary chemotherapy in cT2 N0/1 breast cancer patients: Long-term results of a retrospective study.
    Eur J Surg Oncol. 2017 Aug 10. pii: S0748-7983(17)30607.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: